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Раздел 5. Внутренние болезни, кардиология, 
токсикология, аллергология, эндокринология, 
фармакология, кожные и венерические болезни
The relationship between musculoskeletal pains and the thyroid contains several aspects, including rheumatic 
diseases, such as secondary osteoarthritis (SOA), the most 
common joint pain. Most cases of arthropathy change in 
hypothyroidism (hT) are found in adult, involving knees and 
hands, while the hip and femoral epiphysis occurs more 
frequently in children .
AIM. The estimation of the influence of the disease-modifying 
drug treatment (glucosamine hydrochloride + chondroitin 
sulfate) and intraarticular infiltration with hyaluronic acid 60 mg – 
3ml at patients with osteoarthritis on the base of primary hT.
MATERIAL AND METHODS
In the research were involved 30 patients with primary hT 
diagnosed with SOA, middle aged 46,1±12,32 years-old, 
hospitalized in the endocrinology department, Republican Clinical 
Hospital, divided in two groups: first-formed from 15 patients, 
which used the disease-modifying drug treatment (glucosamine 
hydrochloride + chondroitin sulfate), the second – 15 patients 
which used the disease-modifying drug treatment (glucosamine 
hydrochloride + chondroitin sulfate) in parallel with the local 
treatment – intraarticular infiltration with hyaluronic acid. From 
the study were excluded patients with previous rheumatic and 
cardiac diseases, secondary hT, decompensated liver, lung, 
cancer, kidney diseases. During the study on patients were 
performed clinical examinations, laboratory tests and USG 
examinations. The intensity of pain was appreciated with visual 
analogical scale for pain (VAS) and Lequesne algofunctional 
index.
RESULTS
The middle pain after VAS reported at the beginning of the 
treatment consisted in the first group 55,33±8,96, and for the 
second group 55,33±11,10, after treatment 24,33±11,32 and 
13,67±9,15 respectively. The Lequesne algofunctional index at 
the beginning of the treatment in the first and second group 
consisted 7,4±0,84 and 7,1±0,87 and after 6 months of 
treatment 4±0,66 and 3,5±1,26.
According to the USG data of the affected knee joint was 
determined the shrinking incidence of synovitis in the first group 
from 36,77 to 23,33%, in the second group from 33,33 to 10%. 
The regression stage at USG of gonarthrosis consisted the 
average in the first group 2,6±0,51 to 2,4±0,51, in the second 
group from 2,13±0,64 to 1,86±0,74.
CONCLUSIONS
According to Lequesne score, better results of the treatment 
was stated for the patients from the second group which 
received disease-modifying drug treatment (glucosamine 
hydrochloride +chondroitin sulfate) in parallel with the local 
treatment – intraarticular infiltration with hyaluronic acid. 
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In the last decade great attention of ophthalmologists as abroad and in our country is paid to the problem of the 
syndrome of «dry eye». The urgency of this problem at the 
present time is steadily increasing, due to the wide prevalence 
polyetiological factors and significant impact on the quality of 
life of the patient, his ability to work social and pharmacoeconomic 
aspects.
THE AIM OF STUDY: a comparative analysis of the 
pharmacoeconomic indicators when using the standard therapy 
and combined use solcoseryl, derinat and emoxipin accompanied 
by standard therapy in patients with the syndrome of «dry eye». 
MATERIAL AND METHODS 
In this study, we used a method of pharmacoeconomic 
analysis (in accordance with the National standard of Russia 
